82
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Metastasectomy Improves the Survival of Gastric Cancer Patients with Krukenberg Tumors: A Retrospective Analysis of 182 patients

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 10573-10580 | Published online: 18 Dec 2019

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2 ):69–90. doi:10.3322/caac.v61:221296855
  • Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060 ):2654–2664. doi:10.1016/S0140-6736(16)30354-327156933
  • Kim NK, Kim HK, Park BJ, et al. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma. Cancer-Am Cancer Soc. 1999;85(7 ):1490–1499.
  • Wu XJ, Yuan P, Li ZY, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination. Tumour Biol. 2013;34(1 ):463–469. doi:10.1007/s13277-012-0571-423108893
  • Kim KH, Lee KW, Baek SK, et al. Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer. 2011;14(2 ):130–138. doi:10.1007/s10120-011-0015-721373855
  • Baba Y, Ishikawa S, Ikeda K, et al. A patient with 43 synchronous early gastric carcinomas with a Krukenberg tumor and pericardial metastasis. Gastric Cancer. 2007;10(2 ):135–139. doi:10.1007/s10120-007-0416-917577625
  • Rosa F, Marrelli D, Morgagni P, et al. Krukenberg tumors of gastric origin: the rationale of surgical resection and perioperative treatments in a multicenter western experience. World J Surg. 2016;40(4 ):921–928. doi:10.1007/s00268-015-3326-826552908
  • Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30(3 ):277–299. doi:10.1097/01.pas.0000190787.85024.cb16538048
  • Cho JH, Lim JY, Choi AR, et al. Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with Krukenberg tumor. Cancer Res Treat. 2015;47(4 ):697–705. doi:10.4143/crt.2013.17525648093
  • Lu LC, Shao YY, Hsu CH, et al. Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. Anticancer Res. 2012;32(8 ):3397–3401.22843921
  • Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol. 2004;94(2 ):477–482. doi:10.1016/j.ygyno.2004.05.00715297191
  • Yu P, Huang L, Cheng G, et al. Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China. Oncotarget. 2017;8(47 ):82558–82570. doi:10.18632/oncotarget.1975929137284
  • Mrad K, Morice P, Fabre A, et al. Krukenberg tumor: a clinico-pathological study of 15 cases. Ann Pathol. 2000;20(3 ):202–206.10891713
  • Savey L, Lasser P, Castaigne D, Michel G, Bognel C, Colau JC. [Krukenberg tumors. Analysis of a series of 28 cases]. J Chir (Paris). 1996;133(9–10 ):427–431.9296016
  • Wang J, Shi YK, Wu LY, et al. Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer. 2008;18(4 ):825–832. doi:10.1111/j.1525-1438.2007.01078.x17892453
  • Kim HK, Heo DS, Bang YJ, Kim NK. Prognostic factors of Krukenberg’s tumor. Gynecol Oncol. 2001;82(1 ):105–109. doi:10.1006/gyno.2001.621011426970
  • Jiang R, Tang J, Cheng X, Zang RY. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors. Eur J Surg Oncol. 2009;35(1 ):92–97. doi:10.1016/j.ejso.2008.05.00618632244
  • Peng W, Hua RX, Jiang R, et al. Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis. PLoS ONE. 2013;8(7 ):e68227. doi:10.1371/journal.pone.006822723874550
  • Matsumoto H, Kawazoe A, Shimada K, et al. A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites. BMC Cancer. 2018;18(1 ):120. doi:10.1186/s12885-018-4057-729385993
  • Benizri EI, Bereder JM, Rahili A, Bernard JL, Benchimol D. Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer. Am J Surg. 2013;205(6 ):668–673. doi:10.1016/j.amjsurg.2012.06.00923369310
  • Maeda H, Kobayashi M, Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol. 2015;21(39 ):10936–10947. doi:10.3748/wjg.v21.i39.1093626494952
  • Tseveldorj N, Koklu S, Katipoglu K. An unusual cause of gastric linitis plastica. Gastroenterology. 2016;151(6 ):e10–e11. doi:10.1053/j.gastro.2016.07.019
  • Luu C, Thapa R, Woo K, et al. Does histology really influence gastric cancer prognosis? J Gastrointest Oncol. 2017;8(6 ):1026–1036. doi:10.21037/jgo29299363